Halozyme Therapeutics
HALO
#2396
Rank
C$8.85 B
Marketcap
$69.59
Share price
1.19%
Change (1 day)
34.04%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of September 2024 : C$0.95 Billion

According to Halozyme Therapeutics's latest financial reports the company has C$0.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.44 B-9.47%
2022-12-31C$0.49 B-47.86%
2021-12-31C$0.94 B101.23%
2020-12-31C$0.46 B-14.71%
2019-12-31C$0.55 B13.93%
2018-12-31C$0.48 B-18.14%
2017-12-31C$0.58 B114.15%
2016-12-31C$0.27 B83.29%
2015-12-31C$0.15 B-4.51%
2014-12-31C$0.15 B106.78%
2013-12-31C$76.11 M-23.07%
2012-12-31C$98.94 M84.14%
2011-12-31C$53.73 M-35.43%
2010-12-31C$83.22 M17.24%
2009-12-31C$70.98 M-8.37%
2008-12-31C$77.47 M-20.5%
2007-12-31C$97.44 M89.4%
2006-12-31C$51.44 M130.98%
2005-12-31C$22.27 M15.85%
2004-12-31C$19.22 M2843.29%
2003-12-31C$0.65 M325.3%
2002-12-31C$0.15 M269.03%
2001-12-31C$0.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.36 B-62.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.03 B 428.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.03 B 113.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.25 B 1,393.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.43 B 993.21%๐Ÿ‡ซ๐Ÿ‡ท France
C$29.06 B 2,946.20%๐Ÿ‡บ๐Ÿ‡ธ USA